Eurasian-Origin Gene Segments Contribute to the Transmissibility, Aerosol Release, and Morphology of the 2009 Pandemic H1N1 Influenza Virus
The epidemiological success of pandemic and epidemic influenza A viruses relies on the ability to transmit efficiently from person-to-person via respiratory droplets. Respiratory droplet (RD) transmission of influenza viruses requires efficient replication and release of infectious influenza particles into the air. The 2009 pandemic H1N1 (pH1N1) virus originated by reassortment of a North American triple reassortant swine (TRS) virus with a Eurasian swine virus that contributed the neuraminidase (NA) and M gene segments. Both the TRS and Eurasian swine viruses caused sporadic infections in humans, but failed to spread from person-to-person, unlike the pH1N1 virus. We evaluated the pH1N1 and its precursor viruses in a ferret model to determine the contribution of different viral gene segments on the release of influenza virus particles into the air and on the transmissibility of the pH1N1 virus. We found that the Eurasian-origin gene segments contributed to efficient RD transmission of the pH1N1 virus likely by modulating the release of influenza viral RNA-containing particles into the air. All viruses replicated well in the upper respiratory tract of infected ferrets, suggesting that factors other than viral replication are important for the release of influenza virus particles and transmission. Our studies demonstrate that the release of influenza viral RNA-containing particles into the air correlates with increased NA activity. Additionally, the pleomorphic phenotype of the pH1N1 virus is dependent upon the Eurasian-origin gene segments, suggesting a link between transmission and virus morphology. We have demonstrated that the viruses are released into exhaled air to varying degrees and a constellation of genes influences the transmissibility of the pH1N1 virus.
Vyšlo v časopise:
Eurasian-Origin Gene Segments Contribute to the Transmissibility, Aerosol Release, and Morphology of the 2009 Pandemic H1N1 Influenza Virus. PLoS Pathog 7(12): e32767. doi:10.1371/journal.ppat.1002443
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002443
Souhrn
The epidemiological success of pandemic and epidemic influenza A viruses relies on the ability to transmit efficiently from person-to-person via respiratory droplets. Respiratory droplet (RD) transmission of influenza viruses requires efficient replication and release of infectious influenza particles into the air. The 2009 pandemic H1N1 (pH1N1) virus originated by reassortment of a North American triple reassortant swine (TRS) virus with a Eurasian swine virus that contributed the neuraminidase (NA) and M gene segments. Both the TRS and Eurasian swine viruses caused sporadic infections in humans, but failed to spread from person-to-person, unlike the pH1N1 virus. We evaluated the pH1N1 and its precursor viruses in a ferret model to determine the contribution of different viral gene segments on the release of influenza virus particles into the air and on the transmissibility of the pH1N1 virus. We found that the Eurasian-origin gene segments contributed to efficient RD transmission of the pH1N1 virus likely by modulating the release of influenza viral RNA-containing particles into the air. All viruses replicated well in the upper respiratory tract of infected ferrets, suggesting that factors other than viral replication are important for the release of influenza virus particles and transmission. Our studies demonstrate that the release of influenza viral RNA-containing particles into the air correlates with increased NA activity. Additionally, the pleomorphic phenotype of the pH1N1 virus is dependent upon the Eurasian-origin gene segments, suggesting a link between transmission and virus morphology. We have demonstrated that the viruses are released into exhaled air to varying degrees and a constellation of genes influences the transmissibility of the pH1N1 virus.
Zdroje
1. MorensDMTaubenbergerJK 2011 Pandemic influenza: certain uncertainties. Rev Med Virol 21 262 284
2. Centers for Disease Control and Prevention (CDC) 2009 Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. Morb Mortal Wkly Rep 58 467 470
3. WHO 2010 WHO Global Alert and Response: Pandemic (H1N1) 2009 - update 101, weekly update
4. SubbaraoKKlimovAKatzJRegneryHLimW 1998 Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 393 396
5. KomadinaNRoqueVThawatsuphaPRimando-MagalongJWaicharoenS 2007 Genetic analysis of two influenza A (H1) swine viruses isolated from humans in Thailand and the Philippines. Virus Genes 35 161 165
6. MyersKPOlsenCWGrayGC 2007 Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 44 1084 1088
7. NeumannGNodaTKawaokaY 2009 Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459 931 939
8. ShindeVBridgesCBUyekiTMShuBBalishA 2009 Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360 2616 2625
9. PalasePShawML 2007 Orthomyxoviridae: The viruses and their replication. KnipeDMHowleyPMGriffinDELambRAMartinMA Fields Virology 5th Edition. Philadelphia Wolters Kluwer Health/Lippincott Williams & Wilkins 1647 1689
10. RossmanJSJingXLeserGPLambRA 2010 Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 142 902 913
11. GartenRJDavisCTRussellCAShuBLindstromS 2009 Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 197 201
12. ChouYYAlbrechtRAPicaNLowenACRichtJA 2011 The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol 85 11235 11241
13. YenHLLiangCHWuCYForrestHLFergusonA 2011 Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A 108 14264 14269
14. BelserJAMainesTRTumpeyTMKatzJM 2011 Influenza A virus transmission: contributing factors and clinical implications. Expert Rev Mol Med 12 e39
15. SubbaraoEKLondonWMurphyBR 1993 A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67 1761 1764
16. LowenACSteelJMubarekaSCarneroEGarcia-SastreA 2009 Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol 83 2803 2818
17. TumpeyTMMainesTRVan HoevenNGlaserLSolorzanoA 2007 A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315 655 659
18. GaoYZhangYShinyaKDengGJiangY 2009 Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 5 e1000709
19. Van HoevenNPappasCBelserJAMainesTRZengH 2009 Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A 106 3366 3371
20. HerfstSChutinimitkulSYeJde WitEMunsterVJ 2011 Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol 84 3752 3758
21. MainesTRChenLMVan HoevenNTumpeyTMBlixtO 2011 Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 413 139 147
22. BlachereFMLindsleyWGPearceTAAndersonSEFisherM 2009 Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 48 438 440
23. LindsleyWGBlachereFMDavisKAPearceTAFisherMA 2010 Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis 50 693 698
24. YangWElankumaranSMarrLC 2011 Concentrations and size distributions of airborne influenza A viruses measured indoors at a health centre, a day-care centre and on aeroplanes. J R Soc Interface 8 1176 1184
25. TrokoJMylesPGibsonJHashimAEnstoneJ 2011 Is public transport a risk factor for acute respiratory infection? BMC Infect Dis 11 16
26. ShamanJPitzerVEViboudCGrenfellBTLipsitchM 2010 Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol 8 e1000316
27. LowenACMubarekaSSteelJPaleseP 2007 Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 3 1470 1476
28. YangWMarrLC 2011 Dynamics of airborne influenza a viruses indoors and dependence on humidity. PLoS One 6 e21481
29. ItohYShinyaKKisoMWatanabeTSakodaY 2009 In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460 1021 1025
30. MainesTRJayaramanABelserJAWadfordDAPappasC 2009 Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325 484 487
31. MunsterVJde WitEvan den BrandJMHerfstSSchrauwenEJ 2009 Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325 481 483
32. BelserJAGustinKMMainesTRBlauDMZakiSR 2011 Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic. J Virol 85 1563 1572
33. MainesTRChenLMMatsuokaYChenHRoweT 2006 Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A 103 12121 12126
34. FabianPMcDevittJJDeHaanWHFungROCowlingBJ 2008 Influenza virus in human exhaled breath: an observational study. PLoS One 3 e2691
35. LindsleyWGBlachereFMThewlisREVishnuADavisKA 2010 Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 5 e15100
36. MubarekaSLowenACSteelJCoatesALGarcia-SastreA 2009 Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 199 858 865
37. GustinKMBelserJAWadfordDAPearceMBKatzJM 2011 Influenza virus aerosol exposure and analytical system for ferrets. Proc Natl Acad Sci U S A 108 8432 8437
38. ShtyryaYAMochalovaLVBovinNV 2009 Influenza Virus Neuraminidase: Structure and Function. Acta Naturae 2 26 32
39. BaenzigerJUFieteD 1979 Structure of the complex oligosaccharides of fetuin. J Biol Chem 254 789 795
40. BourmakinaSVGarcia-SastreA 2003 Reverse genetics studies on the filamentous morphology of influenza A virus. J Gen Virol 84 517 527
41. HugheyPGRobertsPCHolsingerLJZebedeeSLLambRA 1995 Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology 212 411 421
42. Smirnov YuAKuznetsovaMAKaverinNV 1991 The genetic aspects of influenza virus filamentous particle formation. Arch Virol 118 279 284
43. JinHLeserGPZhangJLambRA 1997 Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. Embo J 16 1236 1247
44. JayaramanAPappasCRamanRBelserJAViswanathanK 2011 A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One 6 e17616
45. HensleySEDasSRBaileyALSchmidtLMHickmanHD 2009 Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326 734 736
46. SuguitanALJrMarinoMPDesaiPDChenLMMatsuokaY 2009 The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology 395 280 288
47. VerreaultDMoineauSDuchaineC 2008 Methods for sampling of airborne viruses. Microbiol Mol Biol Rev 72 413 444
48. O'DonnellCDSubbaraoK 2011 The contribution of animal models to the understanding of the host range and virulence of influenza A viruses. Microbes Infect 13 502 515
49. ReumanPDKeelySSchiffGM 1989 Assessment of signs of influenza illness in the ferret model. J Virol Methods 24 27 34
50. SteelJLowenACMubarekaSPaleseP 2009 Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog 5 e1000252
51. SorrellEMWanHArayaYSongHPerezDR 2009 Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A 106 7565 7570
52. ChenZWangWZhouHSuguitanALJrShambaughC 2010 Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 84 44 51
53. MinJYChenGLSantosCLamirandeEWMatsuokaY 2010 Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets. Virology 408 128 133
54. ReedLJMuenchH 1938 A simple method of estimating fifty percent endpoints. Am J Hyg 27 493 497
55. ChenGLMinJYLamirandeEWSantosCJinH 2011 Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets. J Infect Dis 203 930 936
56. LambreCRTerzidisHGreffardAWebsterRG 1990 Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods 135 49 57
57. JosephTMcAuliffeJLuBVogelLSwayneD 2008 A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. Virology 378 123 132
58. GlaserLStevensJZamarinDWilsonIAGarcia-SastreA 2005 A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 79 11533 11536
59. HensleySEDasSRGibbsJSBaileyALSchmidtLM 2011 Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. PLoS One 6 e15190
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 12
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Controlling Viral Immuno-Inflammatory Lesions by Modulating Aryl Hydrocarbon Receptor Signaling
- Fungal Virulence and Development Is Regulated by Alternative Pre-mRNA 3′End Processing in
- Epstein-Barr Virus Nuclear Antigen 3C Stabilizes Gemin3 to Block p53-mediated Apoptosis
- Engineered Immunity to Infection